EMI Holding Inactive 10-K2013 FY Annual report

Filed: 8 May 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abstain, accommodate, accuracy, acuity, addiction, adequacy, adjudicated, adversarial, advocacy, age, AIP, aka, Alexander, alleged, alleging, alleviating, altogether, amenable, ancestry, animal, Annex, Aplicada, apportioned, Arapahoe, art, artificial, Attorney, automotive, Avanzate, bar, Bavarian, bilateral, billion, Binomial, Bio, bioavailability, BioMed, biopharmaceutical, bleeding, bribery, broadly, burdensome, buying, cable, cardiovascular, CDC, Centre, Chairperson, characteristic, chemotherapeutic, chemotherapy, circumvent, cliff, Cliquet, CMS, coated, coating, committed, comparison, composite, conceal, condensed, confirmatory, conflict, constrain, construction, constructive, contamination, convenience, convenient, conventional, convince, Corrupt, counter, creditor, Cuc, curtail, curtailment, customary, cyclosporine, debarment, demographic, Dendreon, Denner, depriving, derecognition, detachable, devastating, device, diagnostic, die, disadvantage, disagreement, disapprove, disgorgement, dismissed, dissolved, dissuade, diversified, drain, driven, Duane, East, ed, Eli, enjoy, enlargement, epithelium, EPS, EU, euro, excruciating, expressly, extinguishment, eyelid, factual, FARE, fetal, flammable, footwear, freedom, funeral, gap, GLP, graft, grown, Harvard, HemaQuest, hematologist, HIPAA, HITECH, Holostem, Hospitalier, host, hurt, husband, hydration, illiquid, immigration, immunotherapeutic, importantly, impractical, imprisonment, improper, inflammation, inhibitor, instability, Instituto, instrument, intelligence, inter, intravenously, intrinsic, inventorship, invoke, irreversible, ischemia, Italian, kind, Kurisu, LA, lag, lawfully, left, Lilly, lost, LP, mailing, Mast, matched, median, mesenchymal, mezzanine, Middle, Ming, Miyashita, moiety, molecule, Moni, morbidity, morning, mortality, multilayer, multimedia, municipality, musculoskeletal, nanometer, narrow, narrowed, narrowly, necessarily, negligence, nondeductible, Nordic, North, Obama, occlude, occlusion, occlusive, Offshore, older, onset, opioid, outlook, outpatient, output, parallel, pathophysiology, PCI, peer, penalty, persuade, pharmacovigilance, Phillip, play, pneumonia, polymer, poorly, Portability, possession, potency, potent, poverty, PPACA, precursor, preempted, preissuance, prematurely, premium, prevail, prevailing, privacy, promptly, prorata, provoke, pulmonary, pursuit, quantity, question, qui, Ratchet, ratification, ratified, reassessed, reaudit, rebate, recurrent, redundancy, reexamination, reposition, reputational, residual, restitution, restoration, restored, restoring, restructured, restructuring, revealed, reward, RSU, safeguarding, Sarissa, satisfactorily, Satow, scheme, scrutiny, sector, seller, sequestration, sew, shortly, signature, Similarly, soft, software, Southern, Spain, Specimen, Splenic, Stark, subscription, substantive, surface, swelling, symptom, symptomatic, Taiwanese, tam, Taxpayer, teaching, Terapie, Terasaki, terminology, terrorism, theft, thermal, toHematology, tort, toxic, toxicity, transmit, trapped, TRW, turn, unacceptable, unamortized, unaudited, underway, underwriter, undue, unethical, Universitario, unnecessarily, unnecessary, unrest, unsuccessful, USC, Valladolid, vascular, vaso, versa, Veteran, viability, viral, visceral, visual, war, waste, West, whistleblower, willfully, Winston, wrongful, Yoshiko, young, Yuki

Removed: absolute, applying, blank, Blvd, CA, check, consolidation, exceeding, experiencing, expressing, light, par, participating, penny, planning, preceding, presently, recoverability, shell, tangible, task, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

EMI Holding similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C.
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the annual report of Emmaus Life Sciences, Inc. (the "Company") on Form 10-K for the year ending December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ YUTAKA NIIHARA Yutaka Niihara Chairman of the Board and Chief Executive Officer (Principal Executive Officer) May 8, 2014
/s/ PETER LUDLUM Peter Ludlum Chief Financial Officer (Principal Financial and Accounting Officer) May 8, 2014

QuickLinks

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002